LYEL Lyell Immunopharma, Inc.: Prakiraan rega marang bathi

LYEL (Lyell Immunopharma) - tandha merek perusahaan

Lyell Immunopharma (LYEL) is a biotech startup whose financial model relies on external funding due to the lack of stable earnings during the development phase. This price chart demonstrates a separate_f_pe metric of 0.00. The company's success depends on the outcomes of primary trials for anti-tumor drugs, while existing liquid assets are sufficient to cover current operating expenses.

lyell.com - Pangali mangsa ngarep rega marang bathi LYEL (periode 04.07.2022 - 18.11.2026)

Rincian metrik lan analitis perusahaan lyell.com (LYEL)

- kuotasi lan prakiraan analis:
- data kapitalisasi saham perusahaan:
Analisis fundamental perusahaan:Lyell LYEL
Produk mawa merek Lyell Immunopharma

The assessment of the asset's margin of safety is based on comparing the current price with projected earnings. The innovative T-cell reprogramming ecosystem of Lyell Immunopharma (LYEL) lays the foundation for radical growth in future revenues. The company's forward P/E ratio reflects market expectations regarding the efficacy of this solid tumor therapy. This metric measures the cost of one dollar of expected profit, revealing whether the business is overvalued or undervalued. This tool characterizes the asset as a high-risk venture object.

Analisis perusahaan pesaing

Pangali Forward P/E IBRX|Immunocore Holdings plc (IMCR) - Pangali forward rega marang bathi|Janux Therapeutics Inc - Prakiraan rega marang bathi|Arcus Biosciences (RCUS) - Rasio prakiraan rega marang bathi|ZYME: Prakiraan rega marang bathi|Pangali mangsa ngarep rega marang bathi TNGX (Tango Therapeutics, Inc.)|IOVA: Pangali Forward P/E|IMTX - Kapitalisasi marang proyeksi bathi|Rega marang bathi mangsa ngarep xencor.com|Prakiraan rega marang bathi compasstherapeutics.com (CMPX)|Rega marang bathi mangsa ngarep Replimune Group Inc (REPL)|Prakiraan rega marang bathi Innate Pharma, S.A. IPHA|Pyxis Oncology Inc. - Prakiraan rega marang bathi|Pangali Forward P/E Compugen Ltd. CGEN|IOBT - Rega marang bathi mangsa ngarep|STRO (sutrobio.com) - Rasio rega marang bathi mangsa ngarep|MiNK Therapeutics, Inc (INKT) - Rega marang bathi mangsa ngarep|Rasio prakiraan rega marang bathi Werewolf Therapeutics (HOWL)|Prakiraan rega marang bathi IMMX|ALXO - Pangali forward rega marang bathi|Pangali Forward P/E CUE|Rasio kapitalisasi marang bathi mangsa ngarep PDSB|Pangali Forward P/E SONN (Sonnet BioTherapeutics)|Pangali mangsa ngarep rega marang bathi MAIA|liminatuspharma.com - Pangali Forward P/E|Rasio prakiraan rega marang bathi LAVA Therapeutics|NextCure, Inc. (NXTC) - Rega marang bathi mangsa ngarep|Leap Therapeutics Inc - Pangali mangsa ngarep rega marang bathi|INTS (Intensity Tx) - Pangali Forward P/E|Pangali Forward P/E senseibio.com|Rega marang bathi mangsa ngarep Theriva Biologics (TOVX)|GRTS: Rasio rega marang bathi sing dikarepake|Pangali Forward P/E KA (kinetabio.com)|neximmune.com (NEXI) - Rasio prakiraan rega marang bathi|TSBX: Prakiraan rega marang bathi|VCNX: Rega marang bathi mangsa ngarep|HARP: Pangali Forward P/E